Table 2.
Mean and standard deviation of saliva flow rate and SIgA levels and percentage variation (∆%), upper respiratory illness symptoms and stress symptoms (n = 8). Data are means (±SD).
Baseline
Week 1
Week 2
Week 3
Week 4
Week 5
Saliva flow rate (ml·min
-1
)
.84 (.26)
.91 (.18)
.81 (.17
.81 (.27)
.78 (.32)
.83 (.46)
∆% saliva flow rate
-
12.8 (32.3)
.99 (28.50)
3.49 (41.90)
2.60 (44.7)
.75 (51.3)
SIgA concentration (µg·ml
-1
)
52.2 (32.1)
55.5 (32.3)
78.2 (30.3)
38.8 (16.6)
69.3 (34.9)
59.8 (31.4)
∆% SIgA concentration
-
14.3 (34.1)
67.0 (37.2)
15.0 (27.8)
† †
97.1 (90.7)
35.8 (73.5)
SIgA secretion rate (µg·ml
-1
)
52.2 (59.4)
49.0 (27.1)
61.0 (21.9)
30.3 (13.7)
56.3 (35.3)
49.0 (27.3)
∆% SIgA secretion rate
-
31.7 (68.4)
69.1 (74.7)
10.7 (54.3)
60.0 (127.6)
54.6 (135.7)
URI – total reports
-
-
-
17
3
-
URINo. of affected individuals
-
-
-
2
2
-
URI episodes (max and min)
-
-
-
0 -10
0 – 2
-
Stress symptoms
Stress symptoms (max and min)
-
2.4 (2.2)
(0 – 6)
2.6 (3.4)
(0 – 7)
3.1 (4.5 )
(0 – 11)
2.3 (3.9 )
(0 – 7)
2.6 (3.7)
(0 – 10)
† † p < 0.05, in relation to weeks 2 and 4.